GlassScriptPhysician profile
Michio Kajitani
NPI 1194704387
$8,143.83
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,463 · 2020: $60.72 · 2021: $210 · 2022: $426 · 2023: $486 · 2024: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,909.96 | 2019-2024 | |
| Getinge USA Sales, LLC | $532.39 | 2019-2024 | Vasoview Hemopro 2 |
| Covidien LP | $441.28 | 2019 | |
| Corcym INC | $305.03 | 2023-2024 | Perceval |
| Baxter Healthcare | $261.92 | 2022-2024 | Coseal, Preveleak |
| Medtronic, INC. | $235.74 | 2021-2023 | Corevalve Evolut R, Avalus |
| Edwards Lifesciences Corporation | $213.32 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kci USA, INC. | $117.40 | 2019 | |
| Atricure, INC. | $57.37 | 2019-2022 | |
| Kls-Martin L.P. | $25.43 | 2020 | |
| La Jolla Pharmaceutical Company | $23.08 | 2020 | |
| Abbott Laboratories | $20.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michio Kajitani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.